Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Am J Cardiol. 2021 Oct 27;162:80–85. doi: 10.1016/j.amjcard.2021.09.025

Table 3:

Incidence of stroke/TIA/systemic embolism and bleeding events stratified by the presence of an enzyme inhibiting medication

Outcome* Inhibitor Medication No Interacting Medication p-value
Stroke/TIA/systemic embolism 9.53 (6.41, 13.67) 9.51 (7.51, 11.89) 0.468
Major bleeding 8.80 (5.82, 12.80) 16.30 (13.58, 19.32) 0.0003
Any Bleed 60.20 (51.42, 69.98) 66.70 (60.92, 72.88) 0.0042
*

Events per 1000 patient years (95% confidence intervals).